News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,577 Results
Type
Article (85698)
Company Profile (650)
Press Release (746229)
Section
Business (232020)
Career Advice (4118)
Deals (39682)
Drug Delivery (120)
Drug Development (90671)
Employer Resources (195)
FDA (17942)
Job Trends (17287)
News (395172)
Policy (39608)
Tag
Academia (2972)
Alliances (56544)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (108)
Approvals (17907)
Artificial intelligence (164)
Bankruptcy (396)
Best Places to Work (12499)
Biotechnology (447)
Breast cancer (176)
Cancer (1434)
Career advice (3520)
CAR-T (121)
Cell therapy (346)
Clinical research (71978)
Collaboration (575)
Compensation (263)
COVID-19 (2801)
C-suite (130)
Data (1292)
Diabetes (141)
Diagnostics (6654)
Earnings (94270)
Employer resources (166)
Events (126991)
Executive appointments (438)
FDA (18581)
Funding (473)
Gene therapy (240)
GLP-1 (679)
Government (5042)
Healthcare (20689)
Infectious disease (2884)
Inflammatory bowel disease (128)
Interviews (808)
IPO (17628)
Job creations (5181)
Job search strategy (2857)
Layoffs (504)
Legal (10030)
Lung cancer (216)
Manufacturing (214)
Medical device (14265)
Medtech (14270)
Mergers & acquisitions (22136)
Metabolic disorders (464)
Neuroscience (1745)
NextGen: Class of 2025 (7658)
Non-profit (5055)
Northern California (1698)
Obesity (259)
Opinion (254)
Patents (121)
People (64387)
Pharmaceutical (132)
Phase I (22220)
Phase II (31280)
Phase III (23539)
Pipeline (573)
Postmarket research (3541)
Preclinical (9984)
Radiopharmaceuticals (245)
Rare diseases (281)
Real estate (7373)
Regulatory (26065)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1474)
Startups (4277)
United States (15284)
Vaccines (652)
Weight loss (203)
Date
Today (90)
Last 7 days (509)
Last 30 days (2170)
Last 365 days (32880)
2025 (2176)
2024 (34070)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (222)
Asia (49480)
Australia (8736)
California (3909)
Canada (1289)
China (349)
Colorado (123)
Connecticut (165)
Europe (113206)
Florida (466)
Georgia (107)
Illinois (384)
Indiana (219)
Maryland (679)
Massachusetts (3189)
Michigan (163)
Minnesota (273)
New Jersey (1114)
New York (1100)
North Carolina (862)
Northern California (1698)
Ohio (133)
Pennsylvania (856)
South America (1646)
Southern California (1474)
Texas (513)
Washington State (419)
832,577 Results for "bit bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain
bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, announces the launch of ioAstrocytes.
June 20, 2024
·
5 min read
Press Releases
bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types
January 27, 2025
·
5 min read
Business
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
bit.bio, the company coding human cells for novel cures, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced bit.bio as an inaugural partner of the Ginkgo Technology Network.
February 28, 2024
·
9 min read
Press Releases
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology
October 16, 2024
·
6 min read
Press Releases
bit.bio to Unveil iPSC Advancements and ioCells Toolkit at Society for Neuroscience 2024 Annual Conference
September 30, 2024
·
5 min read
Genetown
bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease
bit.bio, the company coding human cells for novel cures, announces the first project within a multi-year collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research to prioritise the development and delivery of a range of human cell products relevant to Parkinson’s disease.
March 5, 2024
·
5 min read
bit.bio further expands ioCells™️ range with early access launch of ioMotor Neurons™️ for research and drug discovery in diseases such as amyotrophic lateral sclerosis (ALS)
bit.bio, the company coding human cells for novel cures, has launched ioMotor Neurons as its 12th ioCells product this year.
December 6, 2023
·
5 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Business
bit.bio Expands Board of Directors With Appointment of Distinguished Investor, Philanthropist, and Scientist
Weslie Janeway joins bit.bio board.
May 11, 2023
·
4 min read
Genetown
bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for Acute Liver Failure, and Significantly Expands Scientific Advisory Board with Global Experts in Cell Therapy
bit.bio, the company coding human cells for novel cures, announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to enter clinical development in 2025.
November 8, 2023
·
10 min read
1 of 83,258
Next
